The Asia Pacific market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments. The dynamics of the market differs by country, with device adoption hinging largely on positive clinical data and favorable reimbursement in countries such as Australia and South Korea, while device pricing remains a key factor in China and India.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Asia Pacific region across a 10-year period.


Expansion of endovascular clot management procedure volumes hinges on obtaining conclusive evidence demonstrating the comparative efficacy of these procedures over the current standard of care. 

Which segments will experience the strongest growth in procedure volumes?

Which segments will benefit the most from emerging clinical evidence and to what extent?

How will the expanding use of novel oral anticoagulants affect clot management procedures?

What steps are being taken to increase the usage of clot management devices?

What has been the impact of the recent influx of favorable clinical data in the neurovascular thrombectomy device market?

Price consciousness and inadequate reimbursement represent major limiters for the uptake of premium-priced technologies in the Asia Pacific clot management device market.

What effect will varying levels of reimbursement between countries have on their respective markets?

How will cost consciousness among Asia Pacific countries affect device uptake in different product segments?

How will device reuse among cost-conscious facilities affect sales potential?

Results from the ATTRACT clinical trial failed to show the superiority of endovascular treatment for clot management over anticoagulant therapy for treatment of VTE.

How will these negative results impact clot management procedures in the coronary indication in the Asia Pacific region?

Will this data have an impact on the overall clot management device market?

A recent influx of clinical data supporting the effectiveness of neurovascular thrombectomy procedures for the treatment of ischemic stroke will fuel this market segment.

How much growth is expected in this market?

What impact have recent product launches had on the market for neurovascular embolectomy devices?

How long will robust growth in this market be sustained?

Table of contents

  • Asia Pacific
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Clot Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Australia Procedures
        • China Procedures
        • India Procedures
        • South Korea Procedures
      • Competitive Highlights
      • Market Share Rankings
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Local Marketing Strategies
        • Product Portfolio Management
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Clinical Data
        • Pricing Strategies
        • Product Recalls and Safety Issues
      • Market Developments
    • Percutaneous Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Mechanical Thrombectomy Devices
        • Manual Aspiration Thrombectomy Devices
      • Competitive Highlights
      • Market Share Rankings
      • Competitive Factors and Strategies
    • Embolectomy Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Share Rankings
      • Competitive Factors and Strategies
    • Catheter-Directed Thrombolysis Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Share Rankings
      • Competitive Factors and Strategies
    • Inferior Vena Cava Filter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Share Rankings
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Neurovascular Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Clinical Data
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a team lead within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot managment, vascular access, aortic repair, heart valve, structural heart, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Managment from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution. Follow Ashish on Twitter: @Ashishb_DRG.


Related Reports

Clot Management Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments, where device adoption hinges largely on positive cli...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Europe

The European market for clot management devices consists of a combination of rapidly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Japan

The Japanese market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatme...

View Details

Clot Management Devices | Medtech 360 | Market Insights | United States

The US market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details